Jefferies Downgrades Medpace (MEDP) to Hold

July 7, 2026 3:34 AM

Jefferies analyst David Windley downgraded Medpace (NASDAQ: MEDP) from Buy to Hold with a price target of $515.00 (from $490.00).The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found